PM360

MARCH 24, 2023

Cancer-support programs provide vital assistance to patients and their caregivers as they face one of the toughest times of their lives. Yet while patients are interested in these programs, new survey data suggests they aren’t taking advantage of them. We’re committed to serving the entire patient community.”

Patients 98

Patients Education Side effects Media 98

European Pharmaceutical Review

OCTOBER 9, 2023

A new drug, part of a class of chemicals called potassium-channel openers, has demonstrated potential in offering relief to patients with focal epilepsy. Comparatively, patients given a placebo had on average 18 percent fewer seizures during the treatment phase of the trial, which lasted eight weeks.

Side effects 110

Side effects Recruitment Safety Medicine 110

European Pharmaceutical Review

JULY 5, 2022

The availability of oral chemotherapy treatments would provide stomach cancer patients with the option of more efficacious drugs with improved tolerability in a more convenient dosage format” The poor clinical outcomes of stomach cancer make it a key target for drug development. New hope for stomach cancer patients.

Patients 104

Patients Food and Drug Administration Side effects Safety 104

pharmaphorum

JANUARY 9, 2023

Along with Zolgensma – which made its debut in 2019 – Biogen has had approval to market its antisense-based therapy Spinraza (nusinersen) since 2016, while Roche got a green light for its orally-administered therapy Evrysdi (risdiplam) in 2020. ” Zolgensma is one of the most expensive therapies available, with a price tag of around $2.1

Side effects 119

Side effects Patients Management Marketing 119

pharmaphorum

SEPTEMBER 16, 2022

Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable stress in the daily lives of patients and often negatively affect their day-to-day and long-term well-being. However, side effects do happen.

Management 100

Management Side effects Patients Safety 100

pharmaphorum

JANUARY 3, 2023

At the same time, the pharmaceutical industry is creating a greater number of oncology treatments that could provide breakthroughs for patients where none previously existed. Ben Hargreaves examines why there is no easy answer to the question of when palliative care is the right option for patients. The rise of immunotherapies.

Healthcare 105

Healthcare Healthcare Patients Side effects 105

pharmaphorum

JANUARY 3, 2023

The Italian biopharma said it had decided to press ahead with the new study after assessing results from 100 patients with TRS in open-label studies who received the glutamate modulator drug as an add-on to their current therapy for more than six months. in the evenamide group.

Side effects 105

Side effects Biopharma Patients Competition 105

PM360

MAY 25, 2023

And Mental Health America (MHA) found that between 2019 and 2020, 54.7% Currently, OM1 can harness real-world data from clinical notes obtained from more than 9,000 clinicians working in 2,500 clinics across all 50 states, and the company recently added data from more than 148,000 patients with schizophrenia and bipolar this past March.

Side effects 95

Side effects Medical Patients Networking 95

European Pharmaceutical Review

MAY 17, 2023

percent 12-month overall survival (OS) rate for patients with recurrent GBM. Twenty percent of patients with recurrent GBM remained alive for at least three years, and tumour reduction in complete responders continued for more than a year. The median age of patients was 53 years and 41 percent were women.

Engineering 98

Engineering Side effects Medicine Patients 98

Pharmaceutical Technology

AUGUST 26, 2022

As per the Institute for Health Metrics and Evaluation, TB incidence has massively reduced globally in the last few decades, with a fall from 164 cases per 100,000 people in 1990 to 109 cases per 100,000 individuals in 2019. The mortality rate has also reduced from 33 to 15 deaths per 100,000 people from 1990 to 2019.

Side effects 98

Side effects Pharmaceutical Patients Recruitment 98

Pharmaceutical Technology

JULY 29, 2022

While effective at decreasing episodes of agitation for most people with autism, risperidone and aripiprazole have side effects such as sedation, weight gain, and risk of abnormal movements, Veenstra-VanderWeele explains. Generic versions of both drugs are now available. The study results are expected in the H1 next year.

Side effects 105

Side effects Medical Pharmaceutical Management 105

Pharmaceutical Technology

NOVEMBER 29, 2022

In March 2019, the American regulator approved esketamine , an enantiomer of ketamine, for use in treatment-resistant depression as a nasal spray. That research led to a substantial amount of evidence suggesting that ketamine can have rapid effects on a host of measures associated with neuroplasticity,” he says.

Side effects 110

Side effects Pharmaceutical Patients Medicine 110

European Pharmaceutical Review

OCTOBER 19, 2023

These diagnostics have significantly progressed based on rigorous Phase III trial designs and because of the impact these diagnostics have had on patient management. These diagnostics are also paired with therapeutics and act as an imaging biomarker to identify patients who may benefit from the paired therapies.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Side effects Doctors 105

European Pharmaceutical Review

JUNE 12, 2024

The study included 92 adult patients with confirmed CDI. After treatment, patients were followed up at intervals of 72 hours, three weeks, eight weeks, three months and six months. Safety and quality of life of the patients participating in the study were also assessed. percent of those treated with fidaxomicin.

Safety 111

Safety Patients Side effects Healthcare 111

pharmaphorum

JULY 29, 2022

Patients with end-stage renal disease (ESRD) who are on dialysis often need to be treated with anticoagulants to prevent blood clots, but as a result, can experience bleeding side effects. Now, Ionis and Bayer think they have a new drug that could sidestep that risk.

Side effects 72

Side effects FDA Pharma Patients 72

Pharmaceutical Technology

FEBRUARY 13, 2023

While several therapeutics are available for treating symptoms associated with epilepsy, researchers and patients have strongly called out the need for more holistic treatments that would address the condition as a whole. This means that the patient community must drive seed funding for initial research, she adds.

Patients 105

Patients Side effects Medical Engineering 105

Medgadget

MAY 2, 2023

The system uses the patient’s EEG data to calculate a value for the amygdala-derived-EFP biomarker, and meanwhile the patient tries various mental strategies that may help to reduce the value. These treatments at times come with a long list of side effects, leaving many patients in search of an effective long-term solution.

Side effects 86

Side effects Prescription Healthcare Healthcare 86

pharmaphorum

JANUARY 6, 2023

It is estimated there are fewer than 1,000 patients with the disease in the US. Takeda said the drug is the first and only recombinant ADAMTS13 protein in development, and could become a crucial new treatment for patients with cTTP who currently have no therapies approved specifically to manage their condition.

Side effects 59

Side effects Patients Sales Management 59

Pharmaceutical Technology

OCTOBER 13, 2022

Sumitomo acquired its stake in Myovant in 2019 when it paid Roivant Sciences $3bn for stock in five of the holding company’s subsidiaries, which included Myovant.

Food and Drug Administration 52

Food and Drug Administration Pharma Side effects FDA 52

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97

pharmaphorum

JANUARY 3, 2023

” Rawlins was knighted in the 1999 Queen’s New Year Honours for services to the improvement of patient protection from the side effects of medicines, and in 2017 was appointed Knight Grand Cross of the Order of the British Empire (GBE) for services to the safety of medicines, healthcare, and innovation.

Medicine 52

Medicine Side effects Safety Healthcare 52

Evolve Your Success

FEBRUARY 13, 2024

— Watch the episode here Listen to the podcast here Surviving Cancer And Making An Impact To Cancer Patients’ Lives With Rob Ciaramitaro In this episode, we have with us another special guest and he goes by the name of Rob Ciaramitaro. Diagnostic products can change when patients discover their diseases.

Patients 64

Patients Sales Medical sales Doctors 64

pharmaphorum

NOVEMBER 4, 2022

Top of the list of three new pillars of the strategy is a switch from Galapagos’ previous drug discovery approach focused on novel drug targets – which attracted a big alliance with Gilead Sciences but has so far failed to deliver as hoped – to one focused more on patient-centricity and medical need. Jyseleca has made €60.5

Side effects 52

Side effects Safety FDA Sales 52

European Pharmaceutical Review

AUGUST 24, 2022

The ultimate goal of the ADC concept is to maximise the potency of treatment and reduce unwanted side effects on healthy tissues. This excitement will surely propel a next generation of ADCs to patients in cancer indications with a high medical need that are currently not well served with standard of care. About the authors.

Engineering 104

Engineering Side effects Marketing Patients 104

European Pharmaceutical Review

AUGUST 15, 2024

Chronic lymphocytic leukaemia (CLL) is the most prevalent adult leukaemia in Western countries with more than 100,000 incidences and more than 40,000 deaths reported globally in 2019. for patients with del(17p)/ TP53 mutation) and a favourable safety profile, including cardiac events, compared to ibrutinib ( ALPINE study ).

Safety 52

Safety Patients Medical Medicine 52

Clarify Health

JULY 27, 2020

With the sudden physical distance between patients and healthcare facilities imposed by the lockdown, providers proved they could transition to virtual care instantly. At the pandemic’s first peak, non-urgent care services were paused across the US to make way for COVID-19 patients. Is lockdown creating a “hidden pandemic”?

Healthcare 52

Healthcare Healthcare Patients Safety 52

pharmaphorum

DECEMBER 15, 2022

Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. Despite the slap on the wrist, the campaign was highly effective and there is no sign of this approach going away. Connecting peers.

Media 103

Media Healthcare Healthcare Education 103

Pharmaceutical Technology

OCTOBER 10, 2022

The company is aiming to enrol the first patient in the ALETTA Phase III trial in Q1 or Q2 of 2023, says Dr. Jan van der Mooren, Freya’s chief medical officer (CMO). In 2019, the agency authorized the use of Vyleesi, an injectable form of bremelanotide, for the same condition. There are no approved treatments in the EU.

Pharmacology 59

Pharmacology Side effects FDA Safety 59

Impetus Digital

JANUARY 3, 2023

Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. Despite the slap on the wrist, the campaign was highly effective and there is no sign of this approach going away. Connecting Peers.

Media 52

Media Healthcare Healthcare Recruitment 52

World of DTC Marketing

AUGUST 1, 2022

“New weight loss drugs help patients lose significant weight,” but very few are telling the whole story. They can be expensive and have serious side effects. Those capital investment companies’ demand for return on investment and the debt load they force hospices to bear are hurting patients and their families.

Healthcare 234

Healthcare Healthcare Insurance Prescription 234

Pharmaceutical Technology

NOVEMBER 30, 2022

The Health Survey for England 2019 reported that 28% of adults in the UK were obese and 36.2% In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. The UK and US are both undergoing an obesity crisis.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The Health Survey for England 2019 reported that 28% of adults in the UK were obese and 36.2% In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. The UK and US are both undergoing an obesity crisis.

Medical 98

Medical Manufacturing Insurance Side effects 98

Pharmaceutical Technology

JUNE 20, 2023

GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019 [i]. Consent documents often describe technical medical conditions and regulatory bodies are increasing pressure on sponsors to ensure that patient-facing information can be easily understood by patients.

Electronics 52

Electronics Medical Healthcare Training 52